Ticker

Predictive Oncology (NASDAQ: AGPU - Get Free Report) and Profusa (NASDAQ: PFSA - Get Free Report) are both small-cap manufacturing companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, valuation, earnings, risk, dividends, institutional ownership and profitability. Analyst Ratings This is a breakdown of recent

Longevity Health (NASDAQ: XAGE - Get Free Report) and Predictive Oncology (NASDAQ: AGPU - Get Free Report) are both small-cap manufacturing companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, valuation, dividends, profitability, analyst recommendations, institutional ownership and risk. Insider and Institutional Ownership 24.2% of Longevity

PITTSBURGH, Feb. 09, 2026 (GLOBE NEWSWIRE) -- Axe Compute (or the “Company”) (Nasdaq: AGPU) today announced the appointment of Christopher Miglino as Chief Executive Officer, marking a pivotal development in the company's commitment to decentralized compute and digital infrastructure, operating at the intersection of blockchain, AI, and capital markets.

SAN JUAN, Puerto Rico, Jan. 15, 2026 (GLOBE NEWSWIRE) -- DNA Holdings Venture Inc. today announced the release of a comprehensive research report examining Axe Compute (NASDAQ: AGPU) and its role in advancing scalable, revenue-generating AI compute infrastructure powered by real-world GPU networks.

NEW YORK, Dec. 12, 2025 (GLOBE NEWSWIRE) -- Axe Compute Inc. (NASDAQ: AGPU) (the “Company” or “Axe Compute”) today announced that it has changed its name to Axe Compute Inc., with its common stock to begin trading on Nasdaq under the ticker symbol AGPU on December 12, 2025. Axe Compute will continue to operate its AI-driven drug discovery business and plans to expand its business into high-performance enterprise AI…